Report Cover

Global Heparin Sales Market Report 2021


The global Heparin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Heparin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
    Heparin Sodium
    Heparin Calcium
    Other

Segment by Application
    UFH
    LMWH

The Heparin market is analysed and market size information is provided by regions (countries). Segment by Application, the Heparin market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
    Hepalink
    Changshan Pharm
    Qianhong Bio-pharma
    Opocrin
    Pfizer
    Aspen Oss
    King-friend Biochemical Pharmaceutical
    Bioib?(C)rica
    Dongcheng Biochemicals
    Jiulong Biochemicals
    Tiandong
    Xinbai
    Yino Pharma
    Deebio
1 Heparin Market Overview
    1.1 Heparin Product Scope
    1.2 Heparin Segment by Type
        1.2.1 Global Heparin Sales by Type (2016 & 2021 & 2027)
        1.2.2 Heparin Sodium
        1.2.3 Heparin Calcium
        1.2.4 Other
    1.3 Heparin Segment by Application
        1.3.1 Global Heparin Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 UFH
        1.3.3 LMWH
    1.4 Heparin Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Heparin Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Heparin Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Heparin Price Trends (2016-2027)

2 Heparin Estimates and Forecasts by Region
    2.1 Global Heparin Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Heparin Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Heparin Sales Market Share by Region (2016-2021)
        2.2.2 Global Heparin Revenue Market Share by Region (2016-2021)
    2.3 Global Heparin Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Heparin Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Heparin Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Heparin Estimates and Projections (2016-2027)
        2.4.2 Europe Heparin Estimates and Projections (2016-2027)
        2.4.3 China Heparin Estimates and Projections (2016-2027)
        2.4.4 Japan Heparin Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Heparin Estimates and Projections (2016-2027)
        2.4.6 India Heparin Estimates and Projections (2016-2027)
3 Global Heparin Competition Landscape by Players
    3.1 Global Top Heparin Players by Sales (2016-2021)
    3.2 Global Top Heparin Players by Revenue (2016-2021)
    3.3 Global Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Heparin as of 2020)
    3.4 Global Heparin Average Price by Company (2016-2021)
    3.5 Manufacturers Heparin Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Heparin Market Size by Type
    4.1 Global Heparin Historic Market Review by Type (2016-2021)
        4.1.1 Global Heparin Sales Market Share by Type (2016-2021)
        4.1.2 Global Heparin Revenue Market Share by Type (2016-2021)
        4.1.3 Global Heparin Price by Type (2016-2021)
    4.2 Global Heparin Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Heparin Sales Forecast by Type (2022-2027)
        4.2.2 Global Heparin Revenue Forecast by Type (2022-2027)
        4.2.3 Global Heparin Price Forecast by Type (2022-2027)
5 Global Heparin Market Size by Application
    5.1 Global Heparin Historic Market Review by Application (2016-2021)
        5.1.1 Global Heparin Sales Market Share by Application (2016-2021)
        5.1.2 Global Heparin Revenue Market Share by Application (2016-2021)
        5.1.3 Global Heparin Price by Application (2016-2021)
    5.2 Global Heparin Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Heparin Sales Forecast by Application (2022-2027)
        5.2.2 Global Heparin Revenue Forecast by Application (2022-2027)
        5.2.3 Global Heparin Price Forecast by Application (2022-2027)

6 North America Heparin Market Facts & Figures
    6.1 North America Heparin Sales by Company
        6.1.1 North America Heparin Sales by Company (2016-2021)
        6.1.2 North America Heparin Revenue by Company (2016-2021)
    6.2 North America Heparin Sales Breakdown by Type
        6.2.1 North America Heparin Sales Breakdown by Type (2016-2021)
        6.2.2 North America Heparin Sales Breakdown by Type (2022-2027)
    6.3 North America Heparin Sales Breakdown by Application
        6.3.1 North America Heparin Sales Breakdown by Application (2016-2021)
        6.3.2 North America Heparin Sales Breakdown by Application (2022-2027)

7 Europe Heparin Market Facts & Figures
    7.1 Europe Heparin Sales by Company
        7.1.1 Europe Heparin Sales by Company (2016-2021)
        7.1.2 Europe Heparin Revenue by Company (2016-2021)
    7.2 Europe Heparin Sales Breakdown by Type
        7.2.1 Europe Heparin Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Heparin Sales Breakdown by Type (2022-2027)
    7.3 Europe Heparin Sales Breakdown by Application
        7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)

8 China Heparin Market Facts & Figures
    8.1 China Heparin Sales by Company
        8.1.1 China Heparin Sales by Company (2016-2021)
        8.1.2 China Heparin Revenue by Company (2016-2021)
    8.2 China Heparin Sales Breakdown by Type
        8.2.1 China Heparin Sales Breakdown by Type (2016-2021)
        8.2.2 China Heparin Sales Breakdown by Type (2022-2027)
    8.3 China Heparin Sales Breakdown by Application
        8.3.1 China 316 Sales Breakdown by Application (2016-2021)
        8.3.2 China 316 Sales Breakdown by Application (2022-2027)

9 Japan Heparin Market Facts & Figures
    9.1 Japan Heparin Sales by Company
        9.1.1 Japan Heparin Sales by Company (2016-2021)
        9.1.2 Japan Heparin Revenue by Company (2016-2021)
    9.2 Japan Heparin Sales Breakdown by Type
        9.2.1 Japan Heparin Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Heparin Sales Breakdown by Type (2022-2027)
    9.3 Japan Heparin Sales Breakdown by Application
        9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Heparin Market Facts & Figures
    10.1 Southeast Asia Heparin Sales by Company
        10.1.1 Southeast Asia Heparin Sales by Company (2016-2021)
        10.1.2 Southeast Asia Heparin Revenue by Company (2016-2021)
    10.2 Southeast Asia Heparin Sales Breakdown by Type
        10.2.1 Southeast Asia Heparin Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Heparin Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Heparin Sales Breakdown by Application
        10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Heparin Market Facts & Figures
    11.1 India Heparin Sales by Company
        11.1.1 India Heparin Sales by Company (2016-2021)
        11.1.2 India Heparin Revenue by Company (2016-2021)
    11.2 India Heparin Sales Breakdown by Type
        11.2.1 India Heparin Sales Breakdown by Type (2016-2021)
        11.2.2 India Heparin Sales Breakdown by Type (2022-2027)
    11.3 India Heparin Sales Breakdown by Application
        11.3.1 India Heparin Sales Breakdown by Application (2016-2021)
        11.3.2 India Heparin Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Heparin Business
    12.1 Hepalink
        12.1.1 Hepalink Corporation Information
        12.1.2 Hepalink Business Overview
        12.1.3 Hepalink Heparin Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Hepalink Heparin Products Offered
        12.1.5 Hepalink Recent Development
    12.2 Changshan Pharm
        12.2.1 Changshan Pharm Corporation Information
        12.2.2 Changshan Pharm Business Overview
        12.2.3 Changshan Pharm Heparin Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Changshan Pharm Heparin Products Offered
        12.2.5 Changshan Pharm Recent Development
    12.3 Qianhong Bio-pharma
        12.3.1 Qianhong Bio-pharma Corporation Information
        12.3.2 Qianhong Bio-pharma Business Overview
        12.3.3 Qianhong Bio-pharma Heparin Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Qianhong Bio-pharma Heparin Products Offered
        12.3.5 Qianhong Bio-pharma Recent Development
    12.4 Opocrin
        12.4.1 Opocrin Corporation Information
        12.4.2 Opocrin Business Overview
        12.4.3 Opocrin Heparin Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Opocrin Heparin Products Offered
        12.4.5 Opocrin Recent Development
    12.5 Pfizer
        12.5.1 Pfizer Corporation Information
        12.5.2 Pfizer Business Overview
        12.5.3 Pfizer Heparin Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Pfizer Heparin Products Offered
        12.5.5 Pfizer Recent Development
    12.6 Aspen Oss
        12.6.1 Aspen Oss Corporation Information
        12.6.2 Aspen Oss Business Overview
        12.6.3 Aspen Oss Heparin Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Aspen Oss Heparin Products Offered
        12.6.5 Aspen Oss Recent Development
    12.7 King-friend Biochemical Pharmaceutical
        12.7.1 King-friend Biochemical Pharmaceutical Corporation Information
        12.7.2 King-friend Biochemical Pharmaceutical Business Overview
        12.7.3 King-friend Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 King-friend Biochemical Pharmaceutical Heparin Products Offered
        12.7.5 King-friend Biochemical Pharmaceutical Recent Development
    12.8 Bioib?(C)rica
        12.8.1 Bioib?(C)rica Corporation Information
        12.8.2 Bioib?(C)rica Business Overview
        12.8.3 Bioib?(C)rica Heparin Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Bioib?(C)rica Heparin Products Offered
        12.8.5 Bioib?(C)rica Recent Development
    12.9 Dongcheng Biochemicals
        12.9.1 Dongcheng Biochemicals Corporation Information
        12.9.2 Dongcheng Biochemicals Business Overview
        12.9.3 Dongcheng Biochemicals Heparin Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Dongcheng Biochemicals Heparin Products Offered
        12.9.5 Dongcheng Biochemicals Recent Development
    12.10 Jiulong Biochemicals
        12.10.1 Jiulong Biochemicals Corporation Information
        12.10.2 Jiulong Biochemicals Business Overview
        12.10.3 Jiulong Biochemicals Heparin Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Jiulong Biochemicals Heparin Products Offered
        12.10.5 Jiulong Biochemicals Recent Development
    12.11 Tiandong
        12.11.1 Tiandong Corporation Information
        12.11.2 Tiandong Business Overview
        12.11.3 Tiandong Heparin Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Tiandong Heparin Products Offered
        12.11.5 Tiandong Recent Development
    12.12 Xinbai
        12.12.1 Xinbai Corporation Information
        12.12.2 Xinbai Business Overview
        12.12.3 Xinbai Heparin Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 Xinbai Heparin Products Offered
        12.12.5 Xinbai Recent Development
    12.13 Yino Pharma
        12.13.1 Yino Pharma Corporation Information
        12.13.2 Yino Pharma Business Overview
        12.13.3 Yino Pharma Heparin Sales, Revenue and Gross Margin (2016-2021)
        12.13.4 Yino Pharma Heparin Products Offered
        12.13.5 Yino Pharma Recent Development
    12.14 Deebio
        12.14.1 Deebio Corporation Information
        12.14.2 Deebio Business Overview
        12.14.3 Deebio Heparin Sales, Revenue and Gross Margin (2016-2021)
        12.14.4 Deebio Heparin Products Offered
        12.14.5 Deebio Recent Development

13 Heparin Manufacturing Cost Analysis
    13.1 Heparin Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Heparin
    13.4 Heparin Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Heparin Distributors List
    14.3 Heparin Customers

15 Market Dynamics
    15.1 Heparin Market Trends
    15.2 Heparin Drivers
    15.3 Heparin Market Challenges
    15.4 Heparin Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer

List of Tables Table 1. Global Heparin Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027) Table 2. Global Heparin Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027) Table 3. Global Heparin Market Size (US$ Million) by Region: 2016 VS 2021 &2027 Table 4. Global Heparin Sales (K MT) by Region (2016-2021) Table 5. Global Heparin Sales Market Share by Region (2016-2021) Table 6. Global Heparin Revenue (US$ Million) Market Share by Region (2016-2021)) Table 7. Global Heparin Revenue Share by Region (2016-2021) Table 8. Global Heparin Sales (K MT) Forecast by Region (2022-2027) Table 9. Global Heparin Sales Market Share Forecast by Region (2022-2027) Table 10. Global Heparin Revenue (US$ Million) Forecast by Region (2022-2027) Table 11. Global Heparin Revenue Share Forecast by Region (2022-2027) Table 12. Global Heparin Sales (K MT) of Key Companies (2016-2021) Table 13. Global Heparin Sales Share by Company (2016-2021) Table 14. Global Heparin Revenue (US$ Million) by Company (2016-2021) Table 15. Global Heparin Revenue Share by Company (2016-2021) Table 16. Global Heparin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heparin as of 2020) Table 17. Global Heparin Average Price (USD/MT) of Key Company (2016-2021) Table 18. Manufacturers Heparin Manufacturing Sites and Area Served Table 19. Manufacturers Heparin Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Heparin Sales (K MT) by Type (2016-2021) Table 22. Global Heparin Sales Share by Type (2016-2021) Table 23. Global Heparin Revenue (US$ Million) Market Share by Type (2016-2021) Table 24. Global Heparin Price (USD/MT) by Type (2016-2021) Table 25. Global Heparin Sales Share by Type (2022-2027) Table 26. Global Heparin Revenue (US$ Million) Market Share by Type (2022-2027) Table 27. Global Heparin Revenue Share by Type (2022-2027) Table 28. Global Heparin Price (USD/MT) by Type (2022-2027) Table 29. Global Heparin Sales (K MT) by Application (2016-2021) Table 30. Global Heparin Sales Share by Application (2016-2021) Table 31. Global Heparin Revenue (US$ Million) Market Share by Application (2016-2021) Table 32. Global Heparin Price (USD/MT) by Application (2016-2021) Table 33. Global Heparin Sales (K MT) by Application (2022-2027) Table 34. Global Heparin Sales Share by Application (2022-2027) Table 35. Global Heparin Revenue (US$ Million) Market Share by Application (2022-2027) Table 36. Global Heparin Revenue Share by Application (2022-2027) Table 37. Global Heparin Price (USD/MT) by Application (2022-2027) Table 38. North America Heparin Sales (K MT) by Company (2016-2021) Table 39. North America Heparin Sales Market Share by Company (2016-2021) Table 40. North America Heparin Revenue by Company (2016-2021) & (US$ Million) Table 41. North America Heparin Revenue Market Share by Company (2016-2021) Table 42. North America Heparin Sales by Type (2016-2021) & (K MT) Table 43. North America Heparin Sales Market Share by Type (2016-2021) Table 44. North America Heparin Sales by Type (2022-2027) & (K MT) Table 45. North America Heparin Sales Market Share by Type (2022-2027) Table 46. North America Heparin Sales by Application (2016-2021) & (K MT) Table 47. North America Heparin Sales Market Share by Application (2016-2021) Table 48. North America Heparin Sales by Application (2022-2027) & (K MT) Table 49. North America Heparin Sales Market Share by Application (2022-2027) Table 50. Europe Heparin Sales (K MT) by Company (2016-2021) Table 51. Europe Heparin Sales Market Share by Company (2016-2021) Table 52. Europe Heparin Revenue by Company (2016-2021) & (US$ Million) Table 53. Europe Heparin Revenue Market Share by Company (2016-2021) Table 54. Europe Heparin Sales by Type (2016-2021) & (K MT) Table 55. Europe Heparin Sales Market Share by Type (2016-2021) Table 56. Europe Heparin Sales by Type (2022-2027) & (K MT) Table 57. Europe Heparin Sales Market Share by Type (2022-2027) Table 58. Europe Heparin Sales by Application (2016-2021) & (K MT) Table 59. Europe Heparin Sales Market Share by Application (2016-2021) Table 60. Europe Heparin Sales by Application (2022-2027) & (K MT) Table 61. Europe Heparin Sales Market Share by Application (2022-2027) Table 62. China Heparin Sales (K MT) by Company (2016-2021) Table 63. China Heparin Sales Market Share by Company (2016-2021) Table 64. China Heparin Revenue by Company (2016-2021) & (US$ Million) Table 65. China Heparin Revenue Market Share by Company (2016-2021) Table 66. China Heparin Sales by Type (2016-2021) & (K MT) Table 67. China Heparin Sales Market Share by Type (2016-2021) Table 68. China Heparin Sales by Type (2022-2027) & (K MT) Table 69. China Heparin Sales Market Share by Type (2022-2027) Table 70. China Heparin Sales by Application (2016-2021) & (K MT) Table 71. China Heparin Sales Market Share by Application (2016-2021) Table 72. China Heparin Sales by Application (2022-2027) & (K MT) Table 73. China Heparin Sales Market Share by Application (2022-2027) Table 74. Japan Heparin Sales (K MT) by Company (2016-2021) Table 75. Japan Heparin Sales Market Share by Company (2016-2021) Table 76. Japan Heparin Revenue by Company (2016-2021) & (US$ Million) Table 77. Japan Heparin Revenue Market Share by Company (2016-2021) Table 78. Japan Heparin Sales by Type (2016-2021) & (K MT) Table 79. Japan Heparin Sales Market Share by Type (2016-2021) Table 80. Japan Heparin Sales by Type (2022-2027) & (K MT) Table 81. Japan Heparin Sales Market Share by Type (2022-2027) Table 82. Japan Heparin Sales by Application (2016-2021) & (K MT) Table 83. Japan Heparin Sales Market Share by Application (2016-2021) Table 84. Japan Heparin Sales by Application (2022-2027) & (K MT) Table 85. Japan Heparin Sales Market Share by Application (2022-2027) Table 86. Southeast Asia Heparin Sales (K MT) by Company (2016-2021) Table 87. Southeast Asia Heparin Sales Market Share by Company (2016-2021) Table 88. Southeast Asia Heparin Revenue by Company (2016-2021) & (US$ Million) Table 89. Southeast Asia Heparin Revenue Market Share by Company (2016-2021) Table 90. Southeast Asia Heparin Sales by Type (2016-2021) & (K MT) Table 91. Southeast Asia Heparin Sales Market Share by Type (2016-2021) Table 92. Southeast Asia Heparin Sales by Type (2022-2027) & (K MT) Table 93. Southeast Asia Heparin Sales Market Share by Type (2022-2027) Table 94. Southeast Asia Heparin Sales by Application (2016-2021) & (K MT) Table 95. Southeast Asia Heparin Sales Market Share by Application (2016-2021) Table 96. Southeast Asia Heparin Sales by Application (2022-2027) & (K MT) Table 97. Southeast Asia Heparin Sales Market Share by Application (2022-2027) Table 98. India Heparin Sales (K MT) by Company (2016-2021) Table 99. India Heparin Sales Market Share by Company (2016-2021) Table 100. India Heparin Revenue by Company (2016-2021) & (US$ Million) Table 101. India Heparin Revenue Market Share by Company (2016-2021) Table 102. India Heparin Sales by Type (2016-2021) & (K MT) Table 103. India Heparin Sales Market Share by Type (2016-2021) Table 104. India Heparin Sales by Type (2022-2027) & (K MT) Table 105. India Heparin Sales Market Share by Type (2022-2027) Table 106. India Heparin Sales by Application (2016-2021) & (K MT) Table 107. India Heparin Sales Market Share by Application (2016-2021) Table 108. India Heparin Sales by Application (2022-2027) & (K MT) Table 109. India Heparin Sales Market Share by Application (2022-2027) Table 110. Hepalink Corporation Information Table 111. Hepalink Description and Business Overview Table 112. Hepalink Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 113. Hepalink Heparin Product Table 114. Hepalink Recent Development Table 115. Changshan Pharm Corporation Information Table 116. Changshan Pharm Description and Business Overview Table 117. Changshan Pharm Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 118. Changshan Pharm Heparin Product Table 119. Changshan Pharm Recent Development Table 120. Qianhong Bio-pharma Corporation Information Table 121. Qianhong Bio-pharma Description and Business Overview Table 122. Qianhong Bio-pharma Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 123. Qianhong Bio-pharma Heparin Product Table 124. Qianhong Bio-pharma Recent Development Table 125. Opocrin Corporation Information Table 126. Opocrin Description and Business Overview Table 127. Opocrin Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 128. Opocrin Heparin Product Table 129. Opocrin Recent Development Table 130. Pfizer Corporation Information Table 131. Pfizer Description and Business Overview Table 132. Pfizer Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 133. Pfizer Heparin Product Table 134. Pfizer Recent Development Table 135. Aspen Oss Corporation Information Table 136. Aspen Oss Description and Business Overview Table 137. Aspen Oss Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 138. Aspen Oss Heparin Product Table 139. Aspen Oss Recent Development Table 140. King-friend Biochemical Pharmaceutical Corporation Information Table 141. King-friend Biochemical Pharmaceutical Description and Business Overview Table 142. King-friend Biochemical Pharmaceutical Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 143. King-friend Biochemical Pharmaceutical Heparin Product Table 144. King-friend Biochemical Pharmaceutical Recent Development Table 145. Bioib?(C)rica Corporation Information Table 146. Bioib?(C)rica Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 147. Bioib?(C)rica Description and Business Overview Table 148. Bioib?(C)rica Heparin Product Table 149. Bioib?(C)rica Recent Development Table 150. Dongcheng Biochemicals Corporation Information Table 151. Dongcheng Biochemicals Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 152. Dongcheng Biochemicals Description and Business Overview Table 153. Dongcheng Biochemicals Heparin Product Table 154. Dongcheng Biochemicals Recent Development Table 155. Jiulong Biochemicals Corporation Information Table 156. Jiulong Biochemicals Description and Business Overview Table 157. Jiulong Biochemicals Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 158. Jiulong Biochemicals Heparin Product Table 159. Jiulong Biochemicals Recent Development Table 160. Tiandong Corporation Information Table 161. Tiandong Description and Business Overview Table 162. Tiandong Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 163. Tiandong Heparin Product Table 164. Tiandong Recent Development Table 165. Xinbai Corporation Information Table 166. Xinbai Description and Business Overview Table 167. Xinbai Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 168. Xinbai Heparin Product Table 169. Xinbai Recent Development Table 170. Yino Pharma Corporation Information Table 171. Yino Pharma Description and Business Overview Table 172. Yino Pharma Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 173. Yino Pharma Heparin Product Table 174. Yino Pharma Recent Development Table 175. Deebio Corporation Information Table 176. Deebio Description and Business Overview Table 177. Deebio Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 178. Deebio Heparin Product Table 179. Deebio Recent Development Table 180. Production Base and Market Concentration Rate of Raw Material Table 181. Key Suppliers of Raw Materials Table 182. Heparin Distributors List Table 183. Heparin Customers List Table 184. Heparin Market Trends Table 185. Heparin Market Drivers Table 186. Heparin Market Challenges Table 187. Heparin Market Restraints Table 188. Research Programs/Design for This Report Table 189. Key Data Information from Secondary Sources Table 190. Key Data Information from Primary Sources List of Figures Figure 1. Heparin Product Picture Figure 2. Global Heparin Sales Market Share by Type in 2021 & 2027 Figure 3. Type I Product Picture Figure 4. Type II Product Picture Figure 5. Global Heparin Sales Market Share by Application in 2021 & 2027 Figure 6. UFH Examples Figure 7. LMWH Examples Figure 8. Global Heparin Sales, (US$ Million), 2016 VS 2021 VS 2027 Figure 9. Global Heparin Sales Growth Rate (2016-2027) & (US$ Million) Figure 10. Global Heparin Sales (K MT) Growth Rate (2016-2027) Figure 11. Global Heparin Price Trends Growth Rate (2016-2027) (USD/MT) Figure 12. Global Heparin Revenue Market Share by Region: 2016 VS 2021 Figure 13. Global Heparin Revenue Market Share by Region: 2021 VS 2027 Figure 14. North America Heparin Revenue (Million USD) Growth Rate (2016-2027) Figure 15. North America Heparin Sales (K MT) Growth Rate (2016-2027) Figure 16. Europe Heparin Revenue (Million USD) Growth Rate (2016-2027) Figure 17. Europe Heparin Sales (Million USD) Growth Rate (2016-2027) Figure 18. China Heparin Revenue (Million USD) Growth Rate (2016-2027) Figure 19. China Heparin Sales (Million USD) and Growth Rate (2016-2027) Figure 20. Japan Heparin Revenue (Million USD) Growth Rate (2016-2027) Figure 21. Japan Heparin Sales (Million USD) Growth Rate (2016-2027) Figure 22. Southeast Asia Heparin Revenue (Million USD) Growth Rate (2016-2027) Figure 23. Southeast Asia Heparin Sales (Million USD) Growth Rate (2016-2027) Figure 24. India Heparin Revenue (Million USD) Growth Rate (2016-2027) Figure 25. India Heparin Sales (Million USD) Growth Rate (2016-2027) Figure 26. Global 5 Largest Heparin Players Market Share by Revenue in Heparin: 2016 & 2020 Figure 27. Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 28. Global Heparin Revenue Share by Type (2016-2021) Figure 29. Global Heparin Revenue Growth Rate by Type in 2016 & 2020 Figure 30. Global Heparin Revenue Share by Application (2016-2021) Figure 31. Global Heparin Revenue Growth Rate by Application in 2016 & 2020 Figure 32. North America Heparin Sales Market Share by Type in 2020 Figure 33. North America Heparin Sales Market Share by Application in 2020 Figure 34. Europe Heparin Sales Market Share by Type in 2020 Figure 35. Europe Heparin Sales Market Share by Application in 2020 Figure 36. China Heparin Sales Market Share by Type in 2020 Figure 37. China Heparin Sales Market Share by Application in 2020 Figure 38. Japan Heparin Sales Market Share by Type in 2020 Figure 39. Japan Heparin Sales Market Share by Application in 2020 Figure 40. Southeast Asia Heparin Sales Market Share by Type in 2020 Figure 41. Southeast Asia Heparin Sales Market Share by Application in 2020 Figure 42. India Heparin Sales Market Share by Type in 2020 Figure 43. India Heparin Sales Market Share by Application in 2020 Figure 44. Key Raw Materials Price Trend Figure 45. Manufacturing Cost Structure of Heparin Figure 46. Manufacturing Process Analysis of Heparin Figure 47. Heparin Industrial Chain Analysis Figure 48. Channels of Distribution Figure 49. Distributors Profiles Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us